Amerikanische Gesellschaft für Hirudotherapie

Investigating the therapeutic potential of medical leech and leech saliva extract in flap survival: an experimental study using rats

Preclinical study published in Journal of Complementary & Integrative Medicine (2025)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Klinische StudienSpeichel-PharmakologieÜnal K et al. · Journal of complementary & integrative medicine, 2025

Abstract

OBJECTIVES: Medicinal leeches have long been recognized for the bioactive compounds present in their saliva. These compounds have been of interest due to their potential therapeutic properties. This research aimed to explore the impact of both medicinal leech application and the application of medicinal leech saliva extract on wound healing in a rat model with a dorsal random flap in vivo. METHODS: In this in vivo study, a dorsal random skin flap model was created in female Wistar albino rats. Rats were randomly assigned to three groups: control (flap only), medicinal leech therapy (MLT), and leech saliva extract (LSE) injection. Histological, immunohistochemical (VEGF), and ELISA-based biochemical analyses were performed to assess wound healing parameters on postoperative day 7. RESULTS: The flap necrosis area (%) in Group II and Group III was significantly lower than the control group (p<0.05). Vascular Endothelial Growth Factor (VEGF) (+) cell (%), neovascularisation, epithelial regeneration, and granulation tissue thickness in Group II and Group III were significantly higher than the control group (p<0.05). Also, inflammatory cells in group III were substantially lower than in the control group (p<0.05). CONCLUSIONS: To our knowledge, this study is the first in the literature to examine the effect of medicinal leech extract injection in the flap model. These findings emphasize the potential therapeutic benefits of medicinal leeches and their saliva extract in promoting efficient wound healing, with implications for future clinical applications.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsSalivaFemaleRats, WistarWound HealingLeechesSurgical FlapsVascular Endothelial Growth Factor ARatsLeeching

Zusammenfassung

Rat dorsal-flap experimental study comparing intact leech application, topical leech saliva extract, and control on flap survival. Both intact MLT and topical extract improved viable area versus control via enhanced microcirculation and angiogenesis.

Warum dies für die Hirudotherapie relevant ist

This experimental in vivo study examined the impact of medicinal leech therapy (MLT) and leech saliva extract (LSE) injections on wound healing in a rat dorsal random skin flap model. Both MLT and LSE significantly reduced flap necrosis and increased VEGF-positive cells, neovascularization, epithelial regeneration, and granulation tissue thickness compared to controls, with LSE additionally lowering inflammatory cells. The authors conclude these findings emphasize potential therapeutic benefits of medicinal leeches and their saliva extract in promoting efficient wound healing. The primary limitation is that these results derive from an animal model; the abstract notes only 'implications for future clinical applications' and does not confirm human efficacy.

Zitation

Investigating the therapeutic potential of medical leech and leech saliva extract in flap survival: an experimental study using rats.

Ünal K et al. · Journal of complementary & integrative medicine, 2025

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.